Disturbances of basal and postprandial insulin secretion and clearance in obese patients with type 2 diabetes mellitus

Hormone and Metabolic Research

Volumn 44, Issue 1, 2012, Pages 60-69

  Erdmann, J ^a   Phnl, K ^a   Mayr, M ^a   Sypchenko, O ^b   Naumann, A ^a   Wagenpfeil, S ^a   Schusdziarra, V ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

body weight; insulin resistance; insulin secretion; obesity

Indexed keywords

INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZATION;

AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 84855271203     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1295414     Document Type: Article

References (44)

1. Perley M J, Kipnis D M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest: 1967; 46 1954 1962
2. Danowski T S, Lombardo Y B, Mendelsohn L V, Corredor D G, Morgan C R, Sabeh G. Insulin patterns prior to and after onset of diabetes. Metabolism: 1969; 18 731 740
3. Yalow R S, Berson S A. Immunoassay of endogenous plasma insulin in man. J Clin Invest: 1960; 39 1157 1175
4. Karam J H, Grodsky G M, Pavlatos F C, Forsham P H. Critical factors in excessive serum-insulin response to glucose. Obesity in maturity-onset diabetes and growth hormone in acromegaly. Lancet: 1965; 1 286 289
5. Bagdade J D, Bierman E L, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest: 1967; 46 1549 1557
6. Chen K W, Boyko E J, Bergstrom R W, Leonetti D L, Newell-Morris L, Wahl P W, Fujimoto W Y. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Diabetes Care: 1995; 18 747 753
7. Lillioja S, Mott D M, Howard B V, Bennett P H, Yki-Jarvinen H, Freymond D, Nyomba B L, Zurlo F, Swinburn B, Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med: 1988; 318 1217 1225
8. Hovorka R, Chassin L, Luzio S D, Playle R, Owens D R. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab: 1998; 83 744 750 (Pubitemid 28496439)
9. Hovorka R, Albarrak A, Chassin L, Luzio S D, Playle R, Owens D R. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes. Diabet Med: 2001; 18 797 802 (Pubitemid 32953785)
10. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo R A. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia: 2004; 47 31 39 (Pubitemid 38141937)
11. Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes: 1977; 26 944 952 (Pubitemid 8205504)
12. Andrews W J, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven G M. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes: 1984; 33 634 642 (Pubitemid 14087554)
13. Savage P J, Bennion L J, Flock E V, Nagulesparan M, Mott D, Roth J, Unger R H, Bennett P H. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J Clin Endocrinol Metab: 1979; 48 999 1007 (Pubitemid 9190853)
14. Garvey W T, Olefsky J M, Rubenstein A H, Kolterman O G. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion. Diabetes: 1988; 37 590 599
15. Escalante-Pulido M, Escalante-Herrera A, Milke-Najar M E, Alpizar-Salazar M. Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects. Diabetes Nutr Metab: 2003; 16 277 283 (Pubitemid 38180773)
16. Henry R R, Brechtel G, Griver K. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab: 1988; 66 979 986
17. DeFronzo R A, Bonadonna R C, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care: 1992; 15 318 368
18. Goto T, Onuma T, Takebe K, Kral J G. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord: 1995; 12 841 845 (Pubitemid 26003018)
19. Goetz F C, Roel J, Jacobs D R Jr, Barbosa J, Hannan P, Palmer J, Hagopian W. Declining -cell function in type 2 diabetes: 5-year follow-up and immunologic studies of the population of Wadena, MN. Metabolism: 2002; 51 144 148 (Pubitemid 34168223)
20. Reaven G M, Hollenbeck C, Jeng C-Y, Wu M S, Chen Y-DI. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes: 1988; 37 1020 1024 (Pubitemid 19033579)
21. Scarlett J A, Kolterman O G, Ciaraldi T P, Kao M, Olefsky J M. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab: 1983; 56 1195 1201 (Pubitemid 13055113)
22. Liu G, Coulston A, Chen Y D, Reaven G M. Does day-long absolute hypoinsulinemia characterize the patient with non-insulin-dependent diabetes mellitus? Metabolism: 1983; 32 754 756 (Pubitemid 13026341)
23. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab: 2008; 294 E568 E575 (Pubitemid 351355227)
24. Erdmann J, Mayr M, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regul Pept: 2009; 152 1 7
25. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser: 1995; 854 1 452
26. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care: 2003; 26 01 S5 S20
27. Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 7 412 419 (Pubitemid 15018832)
28. Van Cauter E, Mestrez F, Sturis J, Polonsky K S. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes: 1992; 3 368 377
29. Eaton R P, Allen R C, Schade D S, Erickson K M, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab: 1980; 51 520 528 (Pubitemid 10022835)
30. Greenblatt D J, Kochweser J. Drug therapy: clinical pharmacokinetics. N Engl J Med: 1975; 293 702 705
31. Saad M F, Knowler W C, Pettitt D J, Nelson R G, Mott D M, Bennett P H. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet: 1989; 1 1356 1359 (Pubitemid 19151955)
32. Lillioja S, Nyomba B L, Saad M F, Ferraro R, Castillo C, Bennett P H, Bogardus C. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab: 1991; 73 866 876 (Pubitemid 21921951)
33. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med: 1989; 321 337 343 (Pubitemid 19190437)
34. DeFronzo R A, Tobin J D, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol: 1979; 237 E214 E223 (Pubitemid 9249478)
35. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jrvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology: 2008; 135 122 130 (Pubitemid 351899009)
36. Ferrannini E, Wahren J, Faber O K, Felig P, Binder C, DeFronzo R A. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol: 1983; 244 E517 E527 (Pubitemid 13067061)
37. Kotronen A, Vehkavaara S, Seppl-Lindroos A, Bergholm R, Yki-Jrvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab: 2007; 293 E1709 E1715 (Pubitemid 350255123)
38. Polonsky K S, Given B D, Hirsch L J, Tillil H, Shapiro E T, Beebe C, Frank B H, Galloway J A, Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med: 1988; 318 1231 1239
39. Brunzell J D, Robertson R P, Lerner R L, Hazzard W R, Ensinck J W, Bierman E L, Porte D Jr. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab: 1976; 42 222 229
40. Rossetti L, Giaccari A, DeFronzo R A. Glucose toxicity. Diabetes Care: 1990; 13 610 630 (Pubitemid 20169143)
41. Vague P, Moulin J P. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Metabolism: 1982; 31 139 142 (Pubitemid 12222528)
42. Kosaka K, Kuzuya T, Akanuma Y, Hagura R. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia: 1980; 18 23 28 (Pubitemid 10202723)
43. Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care: 2009; 32 375 380
44. Meyer J, Sturis J, Katschinski M, Arnold R, Goke B, Byrne M M. Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose. Am J Physiol Endocrinol Metab: 2002; 282 E917 E922 (Pubitemid 34654754)